All Stories

  1. Human T cells from resistant hypertension patients promote hypertension via tnf in humanized mice
  2. Ten tips to control blood pressure in haemodialysis patients
  3. New Kidneys, Old Risks: Cardiovascular Challenges After Transplantation
  4. Sodium as an Important Regulator of Immunometabolism
  5. Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD
  6. Red blood cell endothelial nitric oxide synthase: A major player in regulating cardiovascular health
  7. Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials
  8. Sodium perturbs mitochondrial respiration and induces dysfunctional Tregs
  9. The Effect of Renal Denervation on T Cells in Patients with Resistant Hypertension
  10. Empagliflozin in Patients with Chronic Kidney Disease
  11. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
  12. Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation
  13. Factors Associated With Vaccine-Induced T-Cell Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 in Kidney Transplant Recipients
  14. 19F-MRT basierte Visualisierung von entzündlichen Prozessen im Gefäßsystem
  15. Cardiomyocyte p38 MAPKα suppresses a heart–adipose tissue–neutrophil crosstalk in heart failure development
  16. Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients
  17. Immune response to third SARS‐CoV‐2 vaccination in seronegative kidney transplant recipients: Possible improvement by mycophenolate mofetil reduction
  18. Immunadsorption zur Herstellung von COVID-19 Antikörperkonzentraten
  19. Development and Validation of Multivariable Prediction Models of Serological Response to SARS-CoV-2 Vaccination in Kidney Transplant Recipients
  20. Inhibition of p38 MAPK decreases hyperglycemia-induced nephrin endocytosis and attenuates albuminuria
  21. Rapid shear stress-dependent ENaC membrane insertion is mediated by the endothelial glycocalyx and the mineralocorticoid receptor
  22. Intensity of mycophenolate mofetil treatment is associated with an impaired immune response to SARS-CoV-2 vaccination in kidney transplant recipients
  23. Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism
  24. Beyond Vessel Diameters: Non-invasive Monitoring of Flow Patterns and Immune Cell Recruitment in Murine Abdominal Aortic Disorders by Multiparametric MRI
  25. COVID-19 antibody donation using immunoadsorption: Report of two cases
  26. Red Blood Cell and Endothelial eNOS Independently Regulate Circulating Nitric Oxide Metabolites and Blood Pressure
  27. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients
  28. Salt Transiently Inhibits Mitochondrial Energetics in Mononuclear Phagocytes
  29. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
  30. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury
  31. Direct Actions of AT 1 (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac Hypertrophy
  32. Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation
  33. Update: Selective adrenal venous sampling (AVS) – Indication, technique, and significance
  34. Proteomic Analysis Reveals Upregulation of ACE2 (Angiotensin-Converting Enzyme 2), the Putative SARS-CoV-2 Receptor in Pressure–but Not Volume-Overloaded Human Hearts
  35. Role of α2-Adrenoceptors in Hypertension: Focus on Renal Sympathetic Neurotransmitter Release, Inflammation, and Sodium Homeostasis
  36. Critical Role of Neprilysin in Kidney Angiotensin Metabolism
  37. Alpha2A-adrenoceptors protect against hypertensive kidney disease.
  38. Platelet reactivity in patients with chronic kidney disease and hemodialysis
  39. Mas receptor deficiency augments angiotensin II-induced atherosclerosis and aortic aneurysm ruptures in hypercholesterolemic male mice
  40. Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70
  41. Renale Rindennekrose nach Gabe von Tranexamsäure bei geburtsassoziierter Blutung
  42. Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage
  43. Isolation of Glomeruli and <em>In Vivo</em> Labeling of Glomerular Cell Surface Proteins
  44. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
  45. Impact of the NO-Sensitive Guanylyl Cyclase 1 and 2 on Renal Blood Flow and Systemic Blood Pressure in Mice
  46. Erythrocyte Salt Sedimentation Assay Does Not Predict Response to Renal Denervation
  47. Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice
  48. A novel in vivo method to quantify slit diaphragm protein abundance in murine proteinuric kidney disease
  49. ACE2 and the Homolog Collectrin in the Modulation of Nitric Oxide and Oxidative Stress in Blood Pressure Homeostasis and Vascular Injury
  50. Resistance to hypertension mediated by intercalated cells of the collecting duct
  51. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction
  52. Macrophages in neuroinflammation: role of the renin-angiotensin-system
  53. Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis
  54. Role of the receptor Mas in macrophage-mediated inflammation in vivo
  55. Acute stimulation of brain mu opioid receptors inhibits glucose-stimulated insulin secretion via sympathetic innervation
  56. Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney
  57. Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension
  58. Impact of Angiotensin Type 1A Receptors in Principal Cells of the Collecting Duct on Blood Pressure and Hypertension
  59. Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension
  60. Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion
  61. Angiotensin II-Induced Hypertension Is Attenuated by Reduction of Sympathetic Output in NO-Sensitive Guanylyl Cyclase 1 Knockout Mice
  62. Skin tight: macrophage-specific COX-2 induction links salt handling in kidney and skin
  63. Coronary artery stenosis: a new risk factor for chronic kidney injury?
  64. Sustained hypertension despite endothelial-specific eNOS rescue in eNOS-deficient mice
  65. Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease
  66. Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease
  67. Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor–mediated kidney fibrosis
  68. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events
  69. Angiotensin-(1–7) Modulates Renal Vascular Resistance Through Inhibition of p38 Mitogen-Activated Protein Kinase in Apolipoprotein E–Deficient Mice
  70. Phosphodiesterase 5 Attenuates the Vasodilatory Response in Renovascular Hypertension
  71. P2Y2 receptor deficiency aggravates chronic kidney disease progression
  72. Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study
  73. AT1 Receptors in the Collecting Duct Directly Modulate the Concentration of Urine
  74. Chronic treatment with angiotensin‐(1‐7) improves renal endothelial dysfunction in apolipoproteinE‐deficient mice
  75. Regulation of renal sympathetic neurotransmission by renal α2A‐adrenoceptors is impaired in chronic renal failure
  76. PKCα Mediates β-Arrestin2-dependent Nephrin Endocytosis in Hyperglycemia
  77. Angiotensin II Type 1A Receptors in Vascular Smooth Muscle Cells Do Not Influence Aortic Remodeling in Hypertension
  78. Treatment of obstructive sleep apnea reduces arterial stiffness
  79. New insights into angiotensin receptor actions: from blood pressure to aging
  80. Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension
  81. The renal resistance index is increased in mild-to-moderate obstructive sleep apnoea and is reduced under continuous positive airway pressure
  82. Influence of genetic background on albuminuria and kidney injury in Ins2+/C96Y (Akita) mice
  83. A Role for Angiotensin II Type 1 Receptors on Bone Marrow-Derived Cells in the Pathogenesis of Angiotensin II–Dependent Hypertension
  84. Small but powerful: Short peptide hormones and their role in autoimmune inflammation
  85. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system
  86. Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting – A case report and review of the literature
  87. The glomerular proteome in a model of chronic kidney disease
  88. A Tale of Two Patients With Mendelian Hypertension
  89. Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase
  90. Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release
  91. Vergleich von Bildgebung und seitengetrennter Nebennierenvenen-Blutentnahme zur Differentialdiagnose bei primärem Hyperaldosteronismus
  92. Sites of inflammation in painful rheumatoid shoulder assessed by musculoskeletal ultrasound and power Doppler sonography
  93. Renaler Widerstandsindex bei obstruktiver Schlafapnoe
  94. α2A‐Adrenoceptors Regulate Sympathetic Transmitter Release in Mice Kidneys
  95. Novel approaches to analyse glomerular proteins from smallest scale murine and human samples using DIGE saturation labelling
  96. Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild-to-moderate hypertension
  97. Angiotensin II modulates renal sympathetic neurotransmission through nitric oxide in AT2 receptor knockout mice
  98. Dihydrotachysterol Therapy for Hypoparathyroidism: Consequences of Inadequate Monitoring. Five Cases and a Review
  99. Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneoulsy hypertensive rats
  100. Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X1,3‐ and P2Y6‐like receptors in mouse perfused kidney
  101. Angiotensin II Receptor Modulation of Renal Vascular Resistance and Neurotransmission in Young and Adult Spontaneously Hypertensive Rats
  102. Modulation of gene expression by moxonidine in rats with chronic renal failure
  103. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y 2 -receptors
  104. Angiotensin-(1–7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats
  105. AT1 and AT2-Receptor Antagonists Inhibit Ang II-Mediated Facilitation of Noradrenaline Release in Human Atria
  106. Effects of angiotensin-(1-7) and other bioactive components of the renin–angiotensin system on vascular resistance and noradrenaline release in rat kidney